Taken together, our data suggest that TIM–3 shedding process can be differentially regulated by ACPA status and serum levels of sTIM–3 could be linked with the elevated levels of inflammatory cytokines in RA patients without high titers of ACPA (<200 U/mL). Here, PRTN3 is linked to rheumatoid arthritis.